Mark Tarr - 20 May 2025 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: President & CEO, Director
Signature: /S/ Stephen Leasure, attorney-in-fact for Mark Tarr
Issuer symbol: EHC
Transactions as of: 20 May 2025
Transactions value $: -$9,640,039
Form type: 4
Filing time: 20 May 2025, 17:08:49 UTC
Previous filing: 05 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tarr Mark J	President & CEO, Director	9001 LIBERTY PARKWAY, BIRMINGHAM	/S/ Stephen Leasure, attorney-in-fact for Mark Tarr	20 May 2025	0001304057

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHC	Encompass Health Common Stock	Options Exercise	$1,974,088	+56,306	+11%	$35.06	583,376	20 May 2025	Direct
transaction	EHC	Encompass Health Common Stock	Options Exercise	$2,773,024	+62,078	+11%	$44.67	645,454	20 May 2025	Direct
transaction	EHC	Encompass Health Common Stock	Sale	-$11,368	-94	-0.01%	$120.94	645,360	20 May 2025	Direct
transaction	EHC	Encompass Health Common Stock	Sale	-$14,375,783	-118,290	-18%	$121.53	527,070	20 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-56,306	-100%	$0	0	20 May 2025	Encompass Health Common Stock	56,306	$35.06	Direct	F2
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-62,078	-100%	$0	0	20 May 2025	Encompass Health Common Stock	62,078	$44.67	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.03 to $121.96, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F2	The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

Content

This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.03 to $121.96, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.